[Clinical features of chronic granulomatous disease]

Wen-jing Ying1, Xiao-chuan Wang, Jin-qiao Sun

  • 1Department of Clinical Immunology, Institute of Pediatrics, Children's Hospital of Fudan University, Shanghai 201102, China.

Insights

Chronic granulomatous disease (CGD) in Chinese children often presents with early onset and recurrent infections. Early diagnosis and treatment with recombinant human interferon-gamma (rhIFN-γ) can improve outcomes for this rare immunodeficiency.

Area of Science:

  • Immunology
  • Genetics
  • Pediatrics

Context:

  • Chronic granulomatous disease (CGD) is a rare primary immunodeficiency.
  • Phagocytic oxidative bursts are impaired in CGD, leading to severe infections and granuloma formation.
  • Limited data exists on CGD clinical characteristics in China.

Purpose:

  • To evaluate the clinical features of 48 Chinese CGD cases.
  • Confirm diagnoses using dihydrorhodamine (DHR) assay and gene mutation analysis.

Summary:

  • The study analyzed 48 Chinese CGD patients diagnosed between 2004 and 2011.
  • All patients were diagnosed by DHR analysis, with onset typically before six months.
  • Common symptoms included recurrent respiratory infections, chronic diarrhea, skin lesions, and lymphadenectasis, often linked to BCG vaccination.
  • Mycobacteria, fungi, and pyogenic bacteria were the primary pathogens.
  • Mutations in CYBB/CYBA/NCF1/NCF2 genes were identified in 37 patients.
  • Treatment with recombinant human interferon-gamma (rhIFN-γ) and sulfamethoxazole reduced disease frequency and severity.

Impact:

  • CGD in this cohort presented with younger age at onset and diagnosis compared to previous reports.
  • Clinical manifestations involved multiple systems, including respiratory, alimentary, skin, and lymph nodes.
  • rhIFN-γ showed potential in improving CGD prognosis.
Abstract

Related Concept Videos

Chronic Inflammation: Introduction01:12

Chronic Inflammation: Introduction

Chronic inflammation is a prolonged, dysregulated immune response that persists for weeks to years when the inciting stimulus is difficult to eradicate or when self‑antigens drive ongoing reactivity. Morphologically, it is defined by mononuclear cell infiltration, progressive tissue destruction, and concurrent attempts at healing via angiogenesis and fibrosis. Compared with acute inflammation, edema is less prominent while cellular infiltration predominates; triggers include persistent...
Chronic Obstructive Pulmonary Disease III: Chronic Bronchitis Features01:24

Chronic Obstructive Pulmonary Disease III: Chronic Bronchitis Features

Chronic bronchitis is a key phenotype of chronic obstructive pulmonary disease (COPD), characterized by airway-centered inflammation and mucus overproduction. It develops from long-term exposure to harmful particles or gases, most commonly cigarette smoke, which triggers a persistent inflammatory response.Cellular and Structural ChangesInflammation initially affects the large bronchi and later the smaller airways, with infiltration by immune cells, including neutrophils, macrophages, and...
Chronic Obstructive Pulmonary Disease IV: Clinical Manifestations01:19

Chronic Obstructive Pulmonary Disease IV: Clinical Manifestations

Chronic Obstructive Pulmonary Disease, or COPD, is a long-term condition marked by persistent and only partially reversible airflow limitation. It involves two overlapping conditions—chronic bronchitis and emphysema—which often co-appear but differ in dominant symptoms and underlying mechanisms.Chronic Bronchitis FeaturesChronic bronchitis presents with a persistent productive cough and thick, sometimes purulent mucus due to airway inflammation, enlarged mucus glands, and goblet cell...
Inflammatory Bowel Disease III: Crohn's Disease01:25

Inflammatory Bowel Disease III: Crohn's Disease

Crohn’s disease is a chronic, relapsing form of inflammatory bowel disease characterized by segmental, transmural inflammation that can affect any part of the gastrointestinal tract. Its pathogenesis arises from a combination of genetic susceptibility, environmental exposures, epithelial barrier dysfunction, and immune dysregulation. Together, these factors lead to an exaggerated immune response against components of the gut microbiome.Genetic and Environmental InfluencesMultiple genetic...
Inflammatory Bowel Disease IV: Clinical Manifestations01:20

Inflammatory Bowel Disease IV: Clinical Manifestations

Inflammatory bowel disease (IBD) encompasses two major chronic disorders—ulcerative colitis and Crohn’s disease—each characterized by relapsing episodes of gastrointestinal inflammation. Although they share certain clinical features, their patterns of involvement and manifestations differ in ways that aid diagnosis and guide management.Ulcerative ColitisUlcerative colitis is limited to the colon and rectum and involves continuous inflammation of the mucosal layer. The disease course is marked...
Inflammatory Bowel Disease II: Crohn's Disease01:30

Inflammatory Bowel Disease II: Crohn's Disease

Introduction
Inflammatory bowel disease, commonly known as IBD, refers to a collection of disorders that lead to persistent inflammation of the gastrointestinal tract. The two types of IBD are ulcerative colitis, which impacts the colon, and Crohn's disease, which can involve any part of the gastrointestinal segment.
Crohn's disease
Crohn's disease is a chronic, systemic inflammatory bowel disease (IBD) that predominantly affects the gastrointestinal tract. It is marked by transmural...